Alpha Teknova (TKNO) Azione Prezzo
Alpha Teknova Prezzo
Negli ultimi 6 anni Alpha Teknova ha aumentato il fatturato del 12,4% all'anno, raggiungendo 40,52 Mio. USD. Per Alpha Teknova, il margine netto del -42,6% risulta in calo rispetto al -26,6% di alcuni anni fa. Il target di prezzo di consenso a 12 mesi per Alpha Teknova è 7,50 USD, circa il 16,8% sopra il prezzo attuale di mercato. Su 14 analisti, 12 valutano il titolo come acquisto — nel complesso un consenso Acquistare.
Alpha Teknova Prezzo delle azioni
Accedi a questi dati tramite l’API Eulerpool
100.000 richieste/mese gratis · nessuna carta di credito
Alpha Teknova Azione e analisi azionaria
Domande frequenti sull'azione Alpha Teknova
The business model of Alpha Teknova Inc revolves around providing innovative solutions in the field of biotechnology. As a leading stock in the industry, Alpha Teknova Inc specializes in the development and manufacturing of various products for life science research, including reagents and kits for molecular biology, cell culture, and genomics. By constantly advancing their technology and maintaining strong relationships with customers, Alpha Teknova Inc has carved a niche for itself in the biotech sector. With a commitment to quality and a focus on meeting the evolving needs of researchers worldwide, Alpha Teknova Inc continues to thrive in the competitive biotechnology market.
Alpha Teknova Inc is primarily active in the biotechnology industry.
Some of the main competitors of Alpha Teknova Inc in the market include XYZ Corporation, ABC Enterprises, and DEF Innovations.
Alpha Teknova Inc is a renowned company in the tech industry. Founded in 2001, Alpha Teknova has a rich history of innovation and success. The company specializes in developing cutting-edge technology solutions for various sectors, including software development, artificial intelligence, and data analytics. With a strong focus on quality and customer satisfaction, Alpha Teknova has become a trusted name in the market. Over the years, the company has earned a stellar reputation for its exceptional products and services, attracting a wide range of clients globally. Alpha Teknova continues to strive for excellence and stay ahead of the competition through continuous research and development.
Alpha Teknova Inc has achieved several significant milestones since its inception. Over the years, the company has established a strong reputation in the industry through its innovative products and services. One noteworthy milestone is the successful development and commercialization of cutting-edge biotechnology solutions, which have revolutionized various research fields. Alpha Teknova Inc has also expanded its market reach by forming strategic partnerships with leading organizations and institutions. Additionally, the company has received numerous accolades for its outstanding contributions to the scientific community. These milestones demonstrate Alpha Teknova Inc's commitment to driving advancements in biotechnology and establishing itself as a leader in the market.
Alpha Teknova Inc primarily operates in the United States.
Alpha Teknova Inc represents a commitment to innovation, quality, and customer satisfaction. Their corporate philosophy is centered around delivering cutting-edge technology solutions to meet the evolving needs of their clients. Alpha Teknova Inc places a strong emphasis on research and development, ensuring their products and services remain at the forefront of their industry. With a focus on collaboration and a passion for excellence, Alpha Teknova Inc strives to provide the highest level of value to their stakeholders. By consistently pushing boundaries and seeking new opportunities, Alpha Teknova Inc continues to establish itself as a leader in the market.
Gli analisti fissano attualmente un prezzo obiettivo medio di 7,50 USD per l’azione Alpha Teknova (mediana: 7,50 USD), pari a +16,8 % rispetto all’ultimo prezzo. Il consenso si basa su 14 giudizi di analisti.
14 analisti valutano attualmente l’azione Alpha Teknova: 12 raccomandano l’acquisto, 2 la tenuta e 0 la vendita. Per il 2026 gli analisti si aspettano per Alpha Teknova ricavi pari a 46,00 Mio. USD e un utile per azione di -0,30 USD.
Convertita al tasso di cambio attuale, l’azione Alpha Teknova quota 5,73 EUR (6,42 USD).
L’azione Alpha Teknova (TKNO) è quotata su 1 borse, tra cui: NASDAQ (TKNO).
Alpha Teknova Inc is a company specialized in the production of biotechnology products. The company was founded in 1996 and is headquartered in California, USA. Alpha Teknova offers a wide range of products, including buffer substances, proteins, enzymes, cultures, and chemical solutions for biotechnology and life sciences. The core business model of Alpha Teknova is to offer solutions to its customers' biotechnological challenges. The company specializes in the development of innovative and custom formulations to meet the needs of its customers. Alpha Teknova focuses on the quality and reliability of its products, as well as continuous improvement of its product range. An important part of Alpha Teknova's business model is its customer service. The company takes into account the needs and requirements of its customers and works closely with them to develop customized solutions. The goal is to provide customers with excellent service and support and establish long-term relationships. Another important division of Alpha Teknova is the production of laboratory equipment. The company offers a wide range of equipment for the life sciences industry, including laboratory and manufacturing facilities. The focus is on producing products that guarantee the highest standards and quality. Another area of Alpha Teknova is the production of waste for the disposal of biotechnological waste. The company produces biodegradable waste bags that dispose of biotechnological waste in a safe and environmentally friendly manner. Alpha Teknova has developed a proven system that is widely used in the industry. Finally, Alpha Teknova also offers training and educational materials for the life sciences industry. The company provides exciting and didactic training programs for students and researchers at all levels. This allows customers to better understand Alpha Teknova's technology and products and improve their research processes. Overall, Alpha Teknova's business model is focused on the needs and requirements of the life sciences industry. The company offers innovative and customized solutions for its customers, always prioritizing quality and customer service. Alpha Teknova has become a leading company in the life sciences industry and will continue to develop innovative products and expand its services.
Il attesa fatturato di Alpha Teknova ammonta a 46,00 Mio. USD. Questo dato si basa sui dati finanziari attuali e riflette lo sviluppo commerciale dell'azienda.
Il attesa profitto di Alpha Teknova ammonta a -16,10 Mio. USD. L'utile netto riflette la redditività dell'azienda dopo la deduzione di tutti i costi.
Il rapporto prezzo/utili (P/E) di Alpha Teknova è attualmente -21,35. Il rapporto P/E confronta il prezzo attuale dell'azione con l'utile per azione e aiuta gli investitori a valutare la valutazione dell'azione Alpha Teknova.
Il rapporto prezzo/fatturato (P/S) di Alpha Teknova è attualmente 7,47. Il rapporto P/S confronta la capitalizzazione di mercato con il fatturato annuo e funge da indicatore di valutazione dell'azione Alpha Teknova.
Il Quality Score AlleAktien per Alpha Teknova è 1/10.
L'ISIN di Alpha Teknova è US02080L1026. L'ISIN (International Securities Identification Number) è un codice identificativo univoco a livello mondiale per i titoli.
Il ticker di Alpha Teknova è TKNO. Con questo simbolo di borsa vengono negoziate le azioni Alpha Teknova in borsa.
Azione Alpha Teknova
Gruppo di pari di Alpha Teknova
Alpha Teknova Ticker
Alpha Teknova FIGI
Altre metriche e analisi di Alpha Teknova in Deep Dive.
La nostra analisi azionaria dell'azione Alpha Teknova include importanti indicatori finanziari come il fatturato, l'utile, il P/E, il P/S, l'EBIT, oltre a informazioni sul dividendo. Inoltre, esaminiamo aspetti come le azioni, la capitalizzazione di mercato, il debito, il patrimonio netto e le passività di Alpha Teknova. Se state cercando informazioni più dettagliate su questi temi, sulle nostre sottopagine offriamo analisi approfondite: